Immodulon Announces Formation of New Scientific Advisory Board to Support Late-stage Clinical Development of IMM-101
Professor Dr. med. Thomas Seufferlein appointed Chair of new Scientific Advisory Board (SAB) composed of leaders with deep expertise in the clinical oncology…